Simple medication check slashes readmission risk for kidney patients?

NCT ID NCT06819527

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a thorough medication review at hospital admission and discharge could reduce mistakes and prevent patients with chronic kidney disease from being readmitted within 90 days. Researchers compared 323 patients who received this extra service to a similar group who got usual care. The goal was to see if careful medication reconciliation leads to fewer errors and better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
medication reconciliation service
What this could lead to
If effective, this approach could become a standard hospital practice to reduce medication mistakes and prevent unnecessary return visits for CKD patients.
What could go wrong
This is a single-center, quasi-experimental study, not a randomized trial, so results may be influenced by unmeasured factors. The intervention is a process change, not a new drug, so impact is modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King Abdullah University Hospital and Princess Basma Hospital

    Irbid, 22110, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.